Commitments and Contingencies (Details) |
6 Months Ended |
|---|---|
|
Dec. 31, 2023
USD ($)
$ / shares
shares
| |
| Commitments and Contingencies [Line Items] | |
| Cash performance rate | 2.00% |
| Revenues gross percentage | 10.00% |
| Average closing price trading days | 10 |
| Warrant [Member] | |
| Commitments and Contingencies [Line Items] | |
| Warrants issued (in Shares) | shares | 500,000 |
| Exercise price (in Dollars per share) | $ / shares | $ 0.15 |
| Revenues (in Dollars) | $ | $ 250,000 |
| X | ||||||||||
- Definition Average closing priced trading days. No definition available.
|
| X | ||||||||||
- Definition The percentage of cash performance. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. No definition available.
|
| X | ||||||||||
- Definition Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income after deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|